Atrial Septal Defect Closure in India & UAE

ASD closure in India from $3,000. Amplatzer device and surgical closure of atrial septal defect at Apollo, Medanta, Fortis. 99% closure rate. Expert cardiologists. Book a free consultation.

Estimated cost: $3,000 – $6,000 · Average stay: 1–3 days

Atrial septal defect closure is the definitive treatment for a significant hole between the two upper chambers of the heart. ASD closure — whether by catheter-delivered device (for suitable secundum ASDs) or by open-heart surgery (for primum, sinus venosus, or large complex defects) — seals the defect permanently, eliminating the left-to-right shunt that causes right heart dilation, pulmonary hypertension, atrial fibrillation, and paradoxical embolism (stroke from clots crossing from the venous to arterial circulation through the ASD).

Catheter-based ASD closure using the Amplatzer Septal Occluder (or equivalent devices — Gore Cardioform ASD, Occlutech Figulla) has revolutionized ASD treatment over the past three decades. What was once exclusively an open-heart surgical procedure requiring sternotomy and cardiopulmonary bypass can now be performed as a day-case procedure through a small vein puncture in the groin — no incisions, no general anesthesia in older children and adults (conscious sedation is sufficient), no cardiopulmonary bypass, and discharge the following morning. The device is loaded onto a catheter, delivered to the left atrium via a transseptal approach, and deployed to permanently close the defect. Over 3–6 months, cardiac tissue grows over the device (endothelialization), achieving complete permanent closure.

India is one of the world's highest-volume centers for transcatheter ASD closure — reflecting the country's large burden of congenital heart disease, the accessibility of major pediatric and adult catheterization programs, and the affordability of the Amplatzer device packages at Indian hospitals. Apollo Hospitals, Fortis Escorts Heart Institute, Narayana Institute of Cardiac Sciences, Medanta – The Medicity, and Sri Jayadeva Institute collectively perform thousands of ASD device closures annually with excellent outcomes.

The cost of transcatheter ASD closure in India — $3,000–$6,000 including the internationally branded Amplatzer device — is 70–80% below US pricing ($15,000–$30,000) and 60–70% below European pricing for the same procedure with the same device.

What Types of ASD Can Be Closed with a Device and Which Need Surgery?

ASD Closure Suitability Assessment:

Catheter Device Closure (suitable for): Secundum ASD (the most common type — in the fossa ovalis) with: adequate tissue rim of at least 5 mm on all sides to anchor the device; defect diameter below 38 mm (the maximum available device size); absence of significant mitral or tricuspid valve impingement by the device on echocardiographic sizing. 3D transesophageal echocardiography (TEE) or intracardiac echocardiography (ICE) is used to precisely measure rim adequacy and confirm device suitability.

Patent Foramen Ovale (PFO) closure: A specialized smaller device (Amplatzer PFO Occluder, Gore Cardioform PFO, Figulla PFO) closes the flap-like PFO in patients with cryptogenic stroke — demonstrated in the RESPECT, REDUCE, DEFENSE-PFO, and CLOSE trials to significantly reduce the risk of recurrent stroke compared to antiplatelet therapy alone in patients under 60 with substantial PFO.

Surgical Closure (required for): Primum ASD (low septal position, adjacent to AV valves — requires direct vision repair and usually mitral cleft repair simultaneously); Sinus venosus ASD (adjacent to SVC/IVC — not suitable for device closure; requires surgical patch and often pulmonary vein rerouting); Large secundum ASD (above 38 mm or with deficient rims — surgical patch closure provides reliable results when device is not feasible); and failed device closure requiring surgical revision.

Who Can Undergo ASD Device Closure?

Catheter device closure is appropriate for: patients above approximately 15 kg body weight (below this weight, the sheaths are too large relative to the femoral vein and iliac vessels — smaller patients undergo surgical closure); secundum ASD with confirmed adequate tissue rim on TEE/ICE; defect diameter below 38 mm; absence of significant rim deficiency adjacent to the aorta (aortic rim deficiency is common and acceptable — device closing to the aortic wall is reliable); and absence of hemodynamically significant co-existing valve disease or other cardiac anomalies requiring concurrent surgery.

PFO closure candidates: cryptogenic stroke (no identifiable cause after full stroke workup) in patients under 60 years; moderate or large PFO with significant right-to-left shunting on bubble contrast echo or TEE; absence of another confirmed stroke cause.

Patients with significant pulmonary arterial hypertension (elevated PVR above 5–6 Wood units) require balloon occlusion test of the ASD before closure — if pulmonary pressures rise and systemic pressures fall with test occlusion, the patient is dependent on the right-to-left shunt through the ASD and closure is contraindicated.

The ASD Device Closure Procedure

ASD device closure is performed in a cardiac catheterization laboratory or hybrid operating room. Protocol:

Preparation: Confirm therapeutic anticoagulation has been adequate to prevent LAA thrombus. TEE or ICE confirms no intracardiac thrombus; confirms ASD anatomy (size, rim adequacy, relationship to adjacent structures). Anesthesia: deep sedation or general anesthesia (required for young children and for TEE guidance); local anesthesia alone for ICE-guided cases in cooperative adults.

Vascular access: Right femoral vein puncture; 8–12 French sheath introduced. Diagnostic catheterization: right heart pressures measured; Qp:Qs calculated.

Transseptal catheterization (if needed): For patients where the catheter cannot pass spontaneously through the ASD due to angulation — a transseptal needle and dilator create a separate crossing point adjacent to the ASD. Most ASDs allow spontaneous catheter passage.

Sizing: A sizing balloon may be used (inflated across the ASD to measure stretched diameter). 3D TEE or ICE provides real-time measurement. Device selected: typically the Amplatzer Septal Occluder or similar, sized at the stretched ASD diameter (or slightly larger).

Device delivery: Delivery sheath advanced into the left atrium; device loaded and advanced through the delivery sheath; left disc expanded in the left atrium and withdrawn against the left side of the septum; right disc expanded in the right atrium. TEE or ICE confirms: device position spanning the ASD completely; no impingement on mitral valve or pulmonary veins; no significant residual shunt on color Doppler.

Device release: The device is released from the delivery cable. Final echo assessment. Sheaths removed; groin compressed.

Procedure Steps

1. Pre-procedure: TEE (secundum ASD rim measurement, 3D sizing); Holter if AF suspected; INR if anticoagulated.
2. Day case admission: fasting 6 hours; IV access; monitoring; consent review.
3. Sedation/anesthesia: conscious sedation (midazolam + fentanyl) for adults; general anesthesia for children and TEE-guided cases.
4. Femoral vein access: right groin; 8–12 French delivery sheath.
5. TEE/ICE probe: real-time guidance throughout; confirms anatomy before, during, and after deployment.
6. Right heart catheterization: PA and RA pressures; Qp:Qs.
7. Catheter passage through ASD: guidewire advanced to left atrium; delivery sheath positioned.
8. Balloon sizing (optional): ASD stretched diameter confirmed.
9. Device selection and loading: correct-size Amplatzer ASO selected; loaded on delivery cable in delivery sheath.
10. Deployment: left disc opened in left atrium; pulled back to septum; right disc opened; 'Minnesota wiggle' confirms stable positioning.
11. Release: TEE/ICE confirms position, no impingement, no residual shunt; cable released.
12. Recovery: groin compressed 15 minutes; 4–6 hours observation; discharge next morning.

Cost Comparison Worldwide

Country — Range — Savings

--- — --- — ---

United States — $15,000 – $35,000 — Baseline

United Kingdom — $8,000 – $20,000 — ~45% savings vs. USA

India — $3,000 – $6,000 — Up to 82% savings vs. USA

UAE — $6,000 – $15,000 — ~60% savings vs. USA

ASD device closure packages in India include: interventional cardiologist fee, catheterization laboratory charges, Amplatzer Septal Occluder or equivalent international-brand device (the major cost item), TEE or ICE guidance, sedation/anesthesia, and 1–2 night hospital stay. Gaf Healthcare specifically confirms that international-brand devices (not domestically manufactured copies) are used at recommended centers.

Recovery & Follow-up

ASD device closure recovery is very rapid. Discharge is the morning after the procedure. The femoral vein puncture site requires light compression for 1–2 hours; there is no arterial puncture, so the strict bed rest required after arterial access is not needed. Immediate ambulation is permitted. Return to normal activities within 24–48 hours; sports and strenuous activity at 4–6 weeks (while device endothelialization completes).

Aspirin 75–150 mg for 6 months prevents device thrombosis during the endothelialization period. Echo at 1 month and 6 months confirms device position and closure completeness. After 6 months, aspirin is discontinued in most patients and annual echocardiography for long-term surveillance continues.

Children recover even more quickly — typically showing dramatic improvement in energy, exercise capacity, and symptom relief within weeks as right ventricular volume overload resolves and the right ventricle begins to decrease in size.

Recovery Tips

• Aspirin 75–150 mg daily for exactly 6 months — take without missing doses to prevent device thrombosis.
• Avoid contact sports, swimming pools, and vigorous activity for 4–6 weeks post-closure.
• Antibiotic prophylaxis before dental procedures for 6 months; not required after confirmed complete endothelialization at 6 months.
• Attend the 1-month and 6-month echocardiograms — confirms device position and monitors RV remodeling.
• MRI safety: Amplatzer devices are MRI-conditional (approved for 1.5T and 3T MRI at 6 weeks from implant); always notify the MRI center.
• Annual echocardiogram thereafter — monitors for late device complications, right ventricular remodeling, and pulmonary pressures.

Risks & Complications

Transcatheter ASD closure is an extremely safe procedure. Major complications are rare: device embolization (0.5–1% — the device dislodges after deployment and must be retrieved by catheter or surgery); cardiac erosion through the atrial wall or aortic root (0.1–0.3% late complication — presenting as pericardial effusion or tamponade; managed surgically; related to oversized device in deficient aortic rim); complete heart block requiring pacemaker (under 0.1%); air embolism (negligible with meticulous technique); and residual shunt (5–10% at 24 hours, falling to under 1% at 6 months as endothelialization completes). Surgical ASD repair (for ineligible device candidates) has the risks of open-heart surgery at their lowest ranges for isolated ASD closure.

Why GAF Healthcare

Gaf Healthcare coordinates transcatheter and surgical ASD closure for patients of all ages — from young children to elderly adults with newly discovered ASDs or PFOs. We confirm device closure eligibility by reviewing the TEE or TTE measurements before recommending catheter versus surgical closure, and confirm that internationally certified devices are used at all recommended centers. Our coordinators arrange the complete procedure including pre-procedure TEE, device closure, 1–2 night hospital stay, and post-closure echocardiographic follow-up.

Frequently Asked Questions

How is ASD closure different from ASD treatment?

These terms are often used interchangeably. ASD treatment refers to the overall management of the defect, which includes assessment, lifestyle considerations, and the closing procedure. ASD closure specifically refers to the act of sealing the defect — either with a catheter-delivered device or surgical patch. Most ASD treatments culminate in closure.

What is the success rate of Amplatzer ASD closure?

The Amplatzer Septal Occluder achieves complete closure (no residual shunt) in 95–99% of cases at 6 months, as cardiac tissue grows over the device. The procedure itself has a success rate (device deployed and stable) above 98% at experienced centers.

Does ASD closure require general anesthesia?

For adults and older children, ASD device closure can be performed under deep conscious sedation (midazolam + fentanyl) when ICE (intracardiac echocardiography) is used for guidance — avoiding general anesthesia entirely. TEE-guided procedures require general anesthesia. Young children require general anesthesia in all cases.

What is the cost of ASD closure in India?

Transcatheter ASD device closure costs $3,000–$6,000 in India — compared to $15,000–$35,000 in the USA. The Amplatzer device itself is the dominant cost; surgical ASD repair costs $3,500–$6,500 in India.